FDA Approved: MAVENCLAD — Supplemental Application (EMD Serono, Inc.)

View source ↗

Summary

The FDA approved a supplemental application for Mavenclad (cladribine) submitted by EMD Serono, Inc., updating the product labeling.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Multiple Sclerosis

Drugs mentioned

• MAVENCLAD (cladribine)

Snippet

SUPPL AP for MAVENCLAD (CLADRIBINE)